InvestorsHub Logo

To infinity and beyond!

12/05/17 6:06 PM

#206224 RE: DaubersUP #206217

similar results to interim will be pretty sweet indeed

for investors and for cancer patients

Enzychem and EC-18 likely 2 years behind....and who knows if they can come close to such results. oh well, cannot count any chickens yet-

untohim

12/05/17 6:11 PM

#206225 RE: DaubersUP #206217

liked this especially from article: against certain types of tumors and therapies to determine parameters for a registration study if the data warrants....comments?